Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,295 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $198.78 | 6 | $0 (2024) |
| Amgen Inc. | $179.00 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $146.17 | 10 | $0 (2024) |
| PFIZER INC. | $110.64 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $88.04 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $72.53 | 4 | $0 (2023) |
| ABBVIE INC. | $65.68 | 4 | $0 (2022) |
| Dexcom, Inc. | $56.58 | 3 | $0 (2024) |
| ViiV Healthcare Company | $49.84 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $49.50 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $391.08 | 21 | Merck Sharp & Dohme LLC ($63.36) |
| 2023 | $435.74 | 24 | AstraZeneca Pharmaceuticals LP ($59.45) |
| 2022 | $352.45 | 19 | Amgen Inc. ($101.64) |
| 2021 | $14.98 | 1 | AstraZeneca Pharmaceuticals LP ($14.98) |
| 2017 | $100.56 | 1 | Merck Sharp & Dohme Corporation ($100.56) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Endocrinology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/24/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: HIV | ||||||
| 07/09/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $32.00 | General |
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 06/10/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Endocrinology | ||||||
| 03/01/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Endocrinology | ||||||
| 01/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardio-renal | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/11/2023 | Sandoz Inc. | HYRIMOZ (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 576 | 983 | $176,795 | $88,503 |
| 2022 | 9 | 556 | 872 | $166,841 | $82,573 |
| 2021 | 5 | 449 | 740 | $154,508 | $71,114 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 367 | $73,400 | $38,770 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 124 | 124 | $37,200 | $16,254 | 43.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 58 | 59 | $17,700 | $10,839 | 61.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 64 | 120 | $21,000 | $10,343 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 81 | $12,150 | $5,937 | 48.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 18 | 22 | $4,400 | $1,967 | 44.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 22 | 31 | $2,325 | $1,634 | 70.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 27 | $4,050 | $1,557 | 38.4% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 28 | 38 | $3,800 | $1,111 | 29.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 31 | 114 | $770.00 | $90.64 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 390 | $79,300 | $41,486 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 216 | 216 | $64,775 | $29,759 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 67 | $11,030 | $5,173 | 46.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 41 | 53 | $3,975 | $2,815 | 70.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 26 | $3,900 | $1,398 | 35.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 13 | 17 | $1,700 | $879.52 | 51.7% |
| 76882 | Limited ultrasound scan of joint or other extremity structure lacking blood vessels | Office | 2022 | 11 | 13 | $1,300 | $644.12 | 49.5% |
| 97760 | Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | Office | 2022 | 11 | 11 | $446.05 | $352.31 | 79.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 18 | 79 | $415.00 | $67.13 | 16.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 123 | 355 | $43,072 | $23,281 | 54.1% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 178 | 186 | $42,036 | $22,551 | 53.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 91 | 91 | $31,500 | $13,358 | 42.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 86 | $19,200 | $9,808 | 51.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 12 | 22 | $18,700 | $2,117 | 11.3% |
About Dr. Joshua Kaye, M.D
Dr. Joshua Kaye, M.D is a Physical Medicine & Rehabilitation healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1386875995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Kaye, M.D has received a total of $1,295 in payments from pharmaceutical and medical device companies, with $391.08 received in 2024. These payments were reported across 66 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,295).
As a Medicare-enrolled provider, Kaye has provided services to 1,581 Medicare beneficiaries, totaling 2,595 services with total Medicare billing of $242,190. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location New York, NY
- Active Since 07/30/2009
- Last Updated 03/07/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386875995
Products in Payments
- SAPHNELO (Biological) $131.88
- ELIQUIS (Drug) $110.64
- JANUVIA (Drug) $100.56
- Kerendia (Drug) $88.04
- EVENITY (Biological) $79.48
- Enbrel (Biological) $69.47
- PIFELTRO (Drug) $66.22
- Dexcom G6 Transmitter (Medical Supply) $56.58
- CUVITRU (Biological) $54.42
- RUKOBIA (Drug) $49.84
- XIFAXAN (Drug) $49.50
- RINVOQ (Biological) $28.62
- Hizentra (Biological) $26.19
- WAKIX (Drug) $24.18
- AVYCAZ (Drug) $24.00
- Nuedexta (Drug) $23.09
- Fluad Quadrivalent (Biological) $22.58
- HYRIMOZ (Drug) $22.58
- Gamunex-C (Biological) $21.00
- HYQVIA (Biological) $18.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in New York
Heidi Fusco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $160,307
Dr. Kimberly Sackheim, Do, DO
Physical Medicine & Rehabilitation — Payments: $158,974
Michael O'dell, Md, MD
Physical Medicine & Rehabilitation — Payments: $103,549
Dr. Craig Antell, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $78,788
Russell Silver, Md, MD
Physical Medicine & Rehabilitation — Payments: $66,937
Ehsan Abdeshahian, Md, MD
Physical Medicine & Rehabilitation — Payments: $54,837